Mirati Therapeutics (MRTX) PT Raised to $90 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts MRTX Hot Sheet
Price: $58.70 --0%
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 16
Rating Summary:
8 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 16
Join SI Premium – FREE
JMP Securities analyst Silvan Tuerkcan raised the price target on Mirati Therapeutics (NASDAQ: MRTX) to $90.00 (from $72.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Hartford Financial Services (HIG) PT Lowered to $136 at Cantor Fitzgerald
- Sterling Construction (STRL) PT Lowered to $565 at Cantor Fitzgerald
- Newell Brands Inc (NWL) PT Raised to $5.75 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
